| Issue Date | Title | Author(s) |
| 2018 | Anti-tumor effects of bemiparin in HepG2 and MIA PaCa-2 cells [Meeting Abstract] | Alur, I.; Dodurga, Y. ; Secme, M.; Elmas, L.; Bagci, G. ; Goksin, I. ; Biray-Avci, C. |
| 2023 | The anticancer effects of thymol on HepG2 cell line | Altıntaş, Fatih ; Tunç-Ata, Melek ; Secme, M.; Küçükatay, Vural |
| 2024 | Biological activities of Liquidambar orientalis: antibiofilm, cytotoxicity, apoptosis, and miRNA expressions | Mutlu, D.; Gunal, B. ; Secme, M.; Kart, N.N.B. ; Mete, G.A. ; Dogan, N.M. ; Semiz, G. |
| 2018 | An evaluation of the differences in DNA damage in lymphocytes and repair efficiencies in patients with schizophrenia and schizoaffective disorder | Topak, Osman Zülkif; Özdel, Osman İsmail ; Dodurga, Y. ; Secme, M. |
| 2023 | Fusaric acid inhibits cell proliferation and downregulates expressions of toll-like receptors pathway genes in Ishikawa endometrial cancer cells | Gulbay, G.; Secme, M.; Mutlu, D. |
| 2015 | MicroRNA -143 and -223 in obesity | Kılıc, İsmail Doğu ; Dodurga, Y. ; Uludag, B.; Alihanoglu, Y.I.; Yildiz, B.S.; Enli, Y. ; Secme, M. |
